These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 25104772)

  • 1. The mycobacterial cell envelope-lipids.
    Jackson M
    Cold Spring Harb Perspect Med; 2014 Aug; 4(10):. PubMed ID: 25104772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of mycolic acids to galectin-3: a novel interaction between a host soluble lectin and trafficking mycobacterial lipids?
    Barboni E; Coade S; Fiori A
    FEBS Lett; 2005 Dec; 579(30):6749-55. PubMed ID: 16310777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methyl-branched fortifications of Mycobacterium tuberculosis.
    Minnikin DE; Kremer L; Dover LG; Besra GS
    Chem Biol; 2002 May; 9(5):545-53. PubMed ID: 12031661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis.
    de Souza MV; Ferreira Mde L; Pinheiro AC; Saraiva MF; de Almeida MV; Valle MS
    ScientificWorldJournal; 2008 Jul; 8():720-51. PubMed ID: 18677428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell envelope glycoconjugates of Mycobacterium tuberculosis.
    Angala SK; Belardinelli JM; Huc-Claustre E; Wheat WH; Jackson M
    Crit Rev Biochem Mol Biol; 2014; 49(5):361-99. PubMed ID: 24915502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some observations of mycobacterial acid-fastness.
    Goren MB; Cernich M; Brokl O
    Am Rev Respir Dis; 1978 Jul; 118(1):151-4. PubMed ID: 79318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Drug Targets in Mycobacterial Cell Wall: Non-Lipid Perspective.
    Das S; Hameed S; Fatima Z
    Curr Drug Discov Technol; 2020; 17(2):147-153. PubMed ID: 29875004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope lipids and pathogenesis.
    Riley LW
    J Clin Invest; 2006 Jun; 116(6):1475-8. PubMed ID: 16741572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis.
    Neyrolles O; Guilhot C
    Tuberculosis (Edinb); 2011 May; 91(3):187-95. PubMed ID: 21330212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of PE11, a cell wall associated esterase, enhances the biofilm growth of Mycobacterium tuberculosis and reduces cell wall virulence lipid levels.
    Rastogi S; Singh AK; Pant G; Mitra K; Sashidhara KV; Krishnan MY
    Microbiology (Reading); 2017 Jan; 163(1):52-61. PubMed ID: 28198348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the mycobacterial envelope for tuberculosis drug development.
    Favrot L; Ronning DR
    Expert Rev Anti Infect Ther; 2012 Sep; 10(9):1023-36. PubMed ID: 23106277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
    Belardinelli JM; Yazidi A; Yang L; Fabre L; Li W; Jacques B; Angala SK; Rouiller I; Zgurskaya HI; Sygusch J; Jackson M
    ACS Infect Dis; 2016 Oct; 2(10):702-713. PubMed ID: 27737557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, function and biogenesis of the mycobacterial cell wall.
    Brennan PJ; Besra GS
    Biochem Soc Trans; 1997 Feb; 25(1):188-94. PubMed ID: 9056869
    [No Abstract]   [Full Text] [Related]  

  • 14. Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.
    Fay A; Czudnochowski N; Rock JM; Johnson JR; Krogan NJ; Rosenberg O; Glickman MS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31239378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information.
    McNeil MR; Brennan PJ
    Res Microbiol; 1991 May; 142(4):451-63. PubMed ID: 1871433
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system.
    Batt SM; Minnikin DE; Besra GS
    Biochem J; 2020 May; 477(10):1983-2006. PubMed ID: 32470138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycolic acids: structures, biosynthesis, and beyond.
    Marrakchi H; Lanéelle MA; Daffé M
    Chem Biol; 2014 Jan; 21(1):67-85. PubMed ID: 24374164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsupported planar lipid membranes formed from mycolic acids of Mycobacterium tuberculosis.
    Langford KW; Penkov B; Derrington IM; Gundlach JH
    J Lipid Res; 2011 Feb; 52(2):272-7. PubMed ID: 21076119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The envelope of mycobacteria.
    Brennan PJ; Nikaido H
    Annu Rev Biochem; 1995; 64():29-63. PubMed ID: 7574484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.